Two Pesticides Linked to Parkinson’s Disease According to NIH Study
The National Institutes of Health (NIH) released the findings of a study conducted by the National Institute of Environmental Health (NIEH), a part of the NIH, in conjunction with the Parkinson’s Institute and Clinical Center which is located in Sunnyvale, California. Announced in the press release of February 11, 2011, the findings show a link between the use of the pesticides paraquat and rotenone and the occurrence of Parkinson’s disease.
The study which implemented control data supplied by the Farming and Movement Evaluation (FAME), evaluated 110 people diagnosed with Parkinson’s disease. The authors of the study were able to evaluate the relationship between the occurrence of Parkinson’s and the use of pesticides documented through FAME’s accumulated case-study information collected on 90,000 licensed pesticide users and their spouses.
The lead author of the study, Dr. Caroline Tanner of the Parkinson’s Institute and Clinical Center states that the findings of this research will assist researchers and doctors in understanding the “biologic changes underlying Parkinson’s disease” which will bring the medical community closer to preventing its occurrence. There are no currently registered uses for rotenone or paraquat in residential or home gardening applications. The use of paraquat is limited to professional and certified pesticide applicators and rotenone is solely for the use of killing one particular invasive species of fish.
The National Institute of Environmental Health is one of the 27 institutes of the NIH and is dedicated to researching the environmental factors effecting human health. The National Institutes of Health as a component of the U.S. Department of Health and Human Services is the U.S. federal agency responsible for spearheading the country’s research into the cures, causes and treatments for rare and common diseases.
Related posts:
- New Research Uncovers Possible Alzheimer’s Genetic Risk Factors
- Naturally Occuring Growth Factor May Enhance Memory
- AMA Study Reveals Lack of Competition in Health Insurance Market
- Projected Costs of Cancer Care and Treatment to Exceed $158 Billion in 2020
- Updated Guide for Schools Teaching Children with Diabetes
- New Website to Inform Physicians for Alternative Medicine Education
- NIH Uncovers Possible Tumor Growth Contributor
- FDA Approves New Medication for COPD Treatment
Posted by L.J. Rogue on Thursday, February 17th, 2011. Filed under Featured News, Health. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry